AATS: American Association for Thoracic Surgery.
Watch the AATS Leadership Video
 
Sunday, May 8, 2011 | AATS/STS Postgraduate Symposia & Lillehei Forum
< Program Index
ABMS COMPETENCIES KEY
Medical
Knowledge		 Interpersonal and
Communication Skills		 Patient
Care		 Practice-Based
Learning and Improvement		 Professionalism System-Based
Practice
This activity has been developed in recognition of the American Board of Medical Specialties Six Core Competencies. This activity will increase your competency in the areas of Patient Care, Medical Knowledge, Systems-Based Practice, Practice-Based Learning and Improvement, and Professionalism. The AATS has designated the primary competency each session will address.
 
7:55 a.m. – 5:00 p.m.   AATS/STS ADULT CARDIAC SURGERY SYMPOSIUM
Chair: John A. Kern, MD
University of Virginia
This symposium will address important new developments and updates in the broad field of adult cardiac surgery, particularly in the areas of aortic and mitral valve disease and therapies, as well as the treatment of thoracic aortic aneurysms, dissections, penetrating ulcers, and intramural hematomas. Participants will have a better understanding of the importance of data management and utilization, and will hear evidence based recommended changes in practice patterns, particularly as they relate to ischemic heart disease. Participants will also hear presentations on the optimal use of pre-operative cardiac imaging, the optimal treatment of hypertrophic cardiomyopathy, techniques for safer re-do cardiac surgery and when to consider LVAD therapy. Panel discussions will follow each session to allow time for questions and answers. 

COURSE OBJECTIVES
At the conclusion of this course, participants will be able to:
  • Appropriately choose and utilize all diagnostic modalities to accurately and completely diagnose patients with valvular heart disease and coronary artery disease and justify the use of each imaging modality.
  • Describe the long-term results of various techniques for surgical coronary revascularization and how they compare to percutaneous stenting, in addition to detailing the long-term patency of various coronary bypass conduits so that surgeons may appropriately and justifiably tailor individual operations for individual patients.
  • Apply evidence-based guidelines to their treatment of patients with aortic valve disease. Specifically, apply the knowledge gained from ongoing clinical trials involving trans-catheter valve therapy to patients with aortic stenosis so that they may more appropriately choose optimal therapy.
  • Select appropriate treatment options and timing of interventions for all patients with aortic dissections. Determine when to intervene on pathologies of the aortic arch and when to utilize endovascular stent graft technologies in light of what is presently known about long-term results of such therapies.
  • Appropriately utilize mitral valve repair technique options when approached with patients with mitral valve insufficiency and appreciate when mitral valve replacement is justified.
  • Gain an appreciation for the long-term limitations of and complications encountered (such as GI bleeding) with LVAD therapy.
7:55 a.m. - 8:00 a.m.   Welcome and Course Overview
John A. Kern, MD
University of Virginia

SESSION I – Aortic Valve
8:00 a.m. - 8:20 a.m.   Does Choice of Prosthesis Really Matter
Neal D. Kon, MD
Wake Forest University
8:20 a.m. - 8:40 a.m.   Patient-Prosthesis Mismatch: Is it for Real
Marc R. Moon, MD
Washington University School of Medicine
8:40 a.m. - 9:00 a.m.   Transcatheter AVR Update
Mathew R. Williams, MD
Columbia University
9:00 a.m. - 9:20 a.m.   Aortic Valve Repair: Technical Aspects and How Much Residual AI Is Too Much
Gebrine El Khoury, MD
St-Luc Hospital
9:20 a.m. - 9:30 a.m.   DISCUSSION
9:30 a.m. - 9:50 a.m.   BREAK

SESSION II – Mitral Valve
9:50 a.m. - 10:10 a.m.   Understanding Mechanisms of MR as a Means to Optimizing Repair: What Have We Learned over 30 Years
W. Randolph Chitwood, Jr., MD
East Carolina University
10:10 a.m. - 10:30 a.m.   What Is the Science (Data) Behind the Use of Neo-Chords
Vinod H. Thourani, MD
Emory University
10:30 a.m. - 10:50 a.m.   Moderate MR Associated with Other Cardiac Pathology: When to Treat
James S. Gammie, MD
University of Maryland
10:50 a.m. - 11:00 a.m.   DISCUSSION

SESSION III – Evidence/Data Based Practices and Ischemic Heart Disease
11:00 a.m. - 11:20 a.m.   Data Reporting, Management, and Utilization: Why Is it Important
T. Bruce Ferguson, Jr., MD
East Carolina University
11:20 a.m. - 11:40 a.m.   New and Creative Strategies for Revascularization: How to Prepare for a Value-Based Reimbursement World
John G. Byrne, MD
Vanderbilt University
11:40 a.m. - 12:00 p.m.   Data/Evidence Based Treatment of Ischemic Heart Disease
David P. Taggart, MD, PhD
University of Oxford
12:00 p.m. - 1:30 p.m.   LUNCH SYMPOSIUM
Evolving technologies: Incorporating New Techniques and Developing Proficiency
Michael J. Mack, MD
Baylor Health Care System

SESSION IV – Thoracic Aortic Disease
1:30 p.m. - 1:50 p.m.   Re-Intervention on Failed Endografts: When and How
Wilson Y. Szeto, MD
University of Pennsylvania
1:50 p.m. - 2:10 p.m.   When and How to Operate on the Aortic Arch
Joseph S. Coselli, MD
Baylor College of Medicine
2:10 p.m. - 2:30 p.m.   Changing Paradigms for the Treatment of Aortic Dissections
G. Michael Deeb, MD University of Michigan
2:30 p.m. - 2:50 p.m.   How Should We Manage Penetrating Ulcers and Intramural Hematomas of the Thoracic Aorta?
Thomas G. Gleason, MD
University of Pittsburgh Medical Center
2:50 p.m. - 3:00 p.m.   DISCUSSION
3:00 p.m. - 3:30 p.m.   BREAK

SESSION V – Special Topics in Adult Cardiac Surgery
3:30 p.m. - 3:50 p.m.   Optimal Utilization of Cardiac MRI in 2011
David D. Yuh, MD
The Johns Hopkins Hospital
3:50 p.m. - 4:10 p.m.   Tips for Safe Re-Operative Heart Surgery
Patrick E. Parrino, MD
Ochsner Clinic Foundation
4:10 p.m. - 4:30 p.m.   Tips for the Optimal Treatment of HCM
Hartzell V. Schaff, MD
Mayo Clinic
4:30 p.m. - 4:50 p.m.   When All Else Fails: LVAD
John V. Conte, MD
The Johns Hopkins Hospital
4:50 p.m. - 5:00 p.m.   DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION IN EXHIBIT HALL
 
8:00 a.m. - 5:00 p.m.   AATS/STS CARDIOTHORACIC CRITICAL CARE SYMPOSIUM
Chairs: Nevin M. Katz, MD
Johns Hopkins University

Michael S. Mulligan, MD
University of Washington Medical Center

Emphasis will be placed on the unique specialty aspects of Cardiovascular-Thoracic (CVT) Critical Care including ECMO, mechanical support, transplant perioperative care, and management of patients after aortic surgery. Fundamental areas of critical care will be presented in a case related format in order to practically relate them to specific cardiothoracic applications. These areas include: evidenced based blood conservation and transfusion guidelines, nutritional support, renal replacement therapies, optimal antibiotic utilization, vasopressor and inotrope support, and arrhythmia management. Significant challenges exist to the establishment of cardiothoracic critical care units at different institutions. A review of relevant issues and potential solutions will be discussed in an open forum and hemodynamic simulation luncheon session. Attendees are encouraged to share the issues and concerns that have arisen at the own institutions.

COURSE OBJECTIVES
At the conclusion of this course, participants will be able to:
  • Describe unique specialty aspects of Cardiovascular-Thoracic (CVT) Critical Care including ECMO and mechanical circulatory support.
  • Integrate nutritional innovations into the practice of CVT Critical Care.
  • Apply evidence-based blood and component transfusion guidelines to clinical practice.
  • Select appropriate anti-microbial agents and practices for treatment and prevention of nosocomial infection including CVL infections.
8:00 a.m. - 8:10 a.m.   Welcome and Opening Remarks
Michael S. Mulligan, MD
University of Washington Medical Center
8:10 a.m. - 8:40 a.m.   CT Critical Care: Challenges and Developments
Nevin M. Katz, MD
Johns Hopkins University
8:40 a.m. - 9:10 a.m.   Cardiovascular Pharmacologic Support
Jerrold H. Levy, MD
Emory University
9:10 a.m. - 9:40 a.m.   Post-Op Cardiac Surgery Arrhythmia Management
Ralph J. Damiano, Jr., MD
Washington University School of Medicine
9:40 a.m. - 10:10 a.m.   Post-Operative Care of LVAD Recipients
Lyle D. Joyce, MD, PhD
Mayo Clinic
10:10 a.m. - 10:30 a.m.   BREAK
10:30 a.m. - 11:00 a.m.   Algorithm for Support of the Failing Heart
Ranjit John, MD
University of Minnesota
11:00 a.m. - 11:30 a.m.   Principles of Aortic Surgery Postoperative Care
Anthony L. Estrera, MD
University of Texas at Houston
11:30 a.m. - 12:00 p.m.   Latest Blood Conservation Protocols
Jerrold H. Levy, MD
Emory University
12:00 p.m. - 1:00 p.m.   Luncheon Symposium – Hemodynamic Simulation
Nevin M. Katz, MD
Johns Hopkins University
1:00 p.m. - 1:30 p.m.   BREAK
1:30 p.m. - 2:00 p.m.   Infection Prophylaxis and Prevention
Dennis G. Maki, MD
University of Wisconsin
2:00 p.m. - 2:30 p.m.   Advanced Ventilator & ECMO Support for Failing Lungs
Robert H. Bartlett, MD
University of Michigan
2:30 p.m. - 3:00 p.m.   Lung Transplant Peri-Operative Care
Michael S. Mulligan, MD
University of Washington Medical Center
3:00 p.m. - 3:15 p.m.   BREAK
3:15 p.m. - 3:45 p.m.   Continuous vs. Intermittent Renal Replacement Therapy
Andrew D. Shaw, MD
Duke University
3:45 p.m. - 4:15 p.m.   C difficile: The New Nosocomial Plague
Dennis G. Maki, MD
University of Wisconsin
4:15 p.m. - 4:45 p.m.   Enteric & Parenteral Nutritional Support – Case Scenarios
Aaron M. Cheng, MD
Harborview Medical Center
4:45 p.m. - 5:00 p.m.   DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION IN EXHIBIT HALL
 
7:55 a.m. - 5:00 p.m.   AATS/STS CONGENITAL HEART DISEASE SYMPOSIUM
Chair: Pedro J. del Nido, MD
Children’s Hospital Boston

Participants will be provided data to assist them in understanding techniques for valve reconstruction covering the spectrum of congenital and acquired valve defects, and the comparative results versus replacement in children. Various options for reconstruction of the regurgitant aortic, mitral, and tricuspid valve will be presented. Faculty will stress the impact of timing of surgery on late outcomes in pulmonary valve insertion and provide an overview of non-invasive imaging techniques for assessing valve function.

COURSE OBJECTIVES
At the conclusion of this course, participants will be able to:
  • Describe the comparative results of valve reconstruction versus replacement in children.
  • List the various options for reconstruction of the regurgitant aortic valve.
  • Discuss the impact of timing of surgery on late outcomes in pulmonary valve insertion.
  • Demonstrate non-invasive imaging techniques for assessing valve function.
7:55 a.m. - 8:00 a.m.   Introduction and Course Overview
Pedro J. del Nido, MD
Children’s Hospital Boston

SESSION I – Aortic Valve Surgery
Moderators: Pedro J. del Nido, MD
Children’s Hospital Boston

Frank L. Hanley, MD
Stanford University
8:00 a.m. - 8:25 a.m.   Aortic Valve Regurgitation: Leaflet Reconstruction Techniques
Gebrine El Khoury, MD
St-Luc Hospital
8:25 a.m. - 8:50 a.m.   Aortic Valve Reconstruction in the Young Infant
Christopher Baird, MD
Children’s Hospital Boston
8:50 a.m. - 9:15 a.m.   Valve Sparing Aortic Root Remodeling
Duke E. Cameron, MD
The Johns Hopkins Hospital
9:15 a.m. - 9:35 a.m.   The Place for the Ross Operation: The “Ideal” Patient
Frank L. Hanley, MD
Stanford University
9:35 a.m. - 10:15 a.m.   CASE DISCUSSIONS
10:15 a.m. - 10:50 a.m.   BREAK

SESSION II – The Pulmonary Valve
Moderators: Emile A. Bacha, MD
Children’s Hospital of New York

James S. Tweddell, MD
Medical College of Wisconsin
10:50 a.m. - 11:20 a.m.   Valve Sparing and Reconstruction Techniques
Emile A. Bacha, MD
Children’s Hospital of New York
11:20 a.m. - 11:40 a.m.   Timing and Techniques for Pulmonary Valve Insertion
James S. Tweddell, MD
Medical College of Wisconsin
11:40 a.m. - 12:00 p.m.   Options for Prosthetic Valve/Conduit Insertion
Sitaram Emani, MD
Children’s Hospital Boston
12:00 p.m. – 1:30 p.m.   LUNCH SYMPOSIUM: Heart Valve Imaging for Surgical Planning
Stephen Sanders, MD
Children’s Hospital Boston

SESSION III – Tricuspid Valve Surgery
Moderators: Joseph A. Dearani, MD
Mayo Clinic

Richard G. Ohye, MD
University of Michigan
1:30 p.m. - 1:50 p.m.   Ebstein’s Anomaly of the Tricuspid Valve: The Cone Repair
Jose Pedro da Silva, MD
Hospital Beneficencia Portuguesa de Sao Paulo
1:50 p.m. - 2:10 p.m.   Tricuspid Regurgitation in Non-Ebstein’s Valve Anomalies
Joseph A. Dearani, MD
Mayo Clinic
2:10 p.m. - 2:30 p.m.   Tricuspid Valve Repair in Single Ventricle: Timing and Techniques
Victor T. Tsang, MD
Great Ormond Street Hospital for Children
2:30 p.m. - 2:50 p.m.   BREAK

SESSION IV – Mitral Valve Reconstruction
Moderators: Pedro J. del Nido, MD
Children’s Hospital Boston

Afksendiyos Kalangos, MD, PhD
University Hospital of Geneva
2:50 p.m. - 3:05 p.m.   Congenital Mitral Stenosis: Morphology and Surgical Approaches
Pedro J. del Nido, MD
Children’s Hospital Boston
3:05 p.m. - 3:25 p.m.   Mitral Regurgitation: Surgical Techniques for Reconstruction
Richard G. Ohye, MD
University of Michigan
3:25 p.m. - 3:45 p.m.   The Rheumatic Mitral Valve and Repair Techniques in Children
Afksendiyos Kalangos, MD, PhD
University Hospital of Geneva
3:45 p.m. - 4:05 p.m.   The Regurgitant Heterotaxy Valve
Shunji Sano, MD, PhD
Okayama University
4:05 p.m. - 4:25 p.m.   Resection/Non-Resection Techniques in Degenerative Mitral Disease in Young Adults
David H. Adams, MD
Mount Sinai Medical Center
4:25 p.m. - 5:00 p.m.   CASE DISCUSSIONS
5:00 p.m.   ADJOURN TO WELCOME RECEPTION IN EXHIBIT HALL
 
8:00 a.m. - 5:00 p.m.   AATS/STS GENERAL THORACIC SURGERY SYMPOSIUM
Chair: David R. Jones, MD
University of Virginia

This symposium features a number of educational formats including didactic lectures, “How-I-Do-It” sessions, and a debate. In addition to other topics, the current status of the management of Pancoast tumors, stage IIIA NSCLC, esophageal diverticuli, and gastroesophageal cancers will be reviewed by experts in the field. In addition, surgeon experts will discuss technical advances and how to avoid potential pitfalls for a number of operative procedures including thoracoscopic thymectomy, VAMLA and TEMLA, VATS segmentectomy, superior vena cava resection, and reconstruction and chest wall resection and reconstruction. Finally, important updates on the current status of lung cancer screening as well as targeted therapies for NSCLC will be presented.

COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
  • Describe the current status of lung cancer screening programs.
  • Outline the indications for and results of surgery for patients with stage III (N2) NSCLC.
  • Apply and modify practice patterns if indicated on the current treatment strategies for Pancoast resections.
  • Develop an understanding of current applications and indication for targeted therapies in lung cancer patients.
  • Evaluate and manage intrathoracic esophageal diverticuli.
  • Assess and appreciate differences in the surgical approach to repair of giant paraesophageal hiatal hernias.
  • Discuss the optimal therapy for GE junction tumors.
  • Appreciate and become familiar with new technical approaches to perform a minimally-invasive esophagectomy.
  • Delineate the various treatment modalities for managing an esophageal leak.
  • List current evidence-based recommendations for induction and adjuvant therapies for lymph node positive esophageal cancer.
  • Describe the important technical and procedural components to perform several operations including thoracoscopic thymectomy, VATS lymph nodal dissection, VATS segmentectomy, superior vena cava resection, and chest wall resection and reconstruction.
  • Describe potential technical pitfalls and how to avoid them to improve clinical results in the operative procedures listed above.
8:00 a.m. - 8:10 a.m.   Introduction and Course Overview
David R. Jones, MD
University of Virginia

SESSION I – Lung Cancer
8:10 a.m. - 8:30 a.m.   Current Status of Lung Cancer Screening
Frank C. Detterbeck, MD
Yale University
8:30 a.m. - 9:00 a.m.   Current Surgical Therapy for Stage IIIA (N2) NSCLC
Valerie W. Rusch, MD
Memorial Sloan-Kettering Cancer Center
9:00 a.m. - 9:30 a.m.   Trimodality Therapy for Pancoast Tumors: Results and Outcomes
David H. Harpole, Jr., MD
Duke University
9:30 a.m. - 10:00 a.m.   Targeted Therapy for NSCLC: Which Drug for Which Patient?
Mark A. Socinski, MD
University of North Carolina
10:00 a.m. - 10:30 a.m.   BREAK
SESSION II – Benign Esophageal Disease
10:30 a.m. – 10:50 a.m.   Evaluation and Management of Intrathoracic Esophageal Diverticuli
Benjamin D. Kozower, MD, MPH
University of Virginia
10:50 a.m. - 11:20 a.m.   Surgical Management of End-Stage Achalasia
Stephen C. Yang, MD
The Johns Hopkins Hospital
11:20 a.m. - 12:00 p.m.   Surgical Controversies: Open vs. Laparoscopic Repair of Giant Paraesophageal Hiatal Hernia (GPEH) Open Thoracotomy Is Best for GPEH
Henning A. Gaissert, MD
Massachusetts General Hospital

Laparoscopic Repair Is Best for GPEH
Michael A. Maddaus, MD
University of Minnesota
12:00 p.m. - 1:30 p.m.   LUNCH SYMPOSIUM: Why We Make Mistakes: Impact on Quality and What Surgeons Can Do About It
Jeffrey S. Young, MD
University of Virginia

SESSION III – Esophageal Cancer
1:30 p.m. - 2:00 p.m.   Optimal Therapy for GE Junction Tumors
Steven G. Swisher, MD
MD Anderson Cancer Center
2:00 p.m. - 2:20 p.m.   Technical Tips for Performing a Minimally Invasive Esophagectomy
Bryan F. Meyers, MD, MPH
Washington University School of Medicine
2:20 p.m. - 2:40 p.m.   Management of the Post-Esophagectomy Anastomotic Leak
James S. Allan, MD
Massachusetts General Hospital
2:40 p.m. - 3:00 p.m.   Induction and Adjuvant Therapies for Node-Positive Esophageal Cancer
Gail E. Darling, MD
University of Toronto
3:00 p.m. - 3:30 p.m.   BREAK
SESSION IV – Surgical Techniques: How I Do It
3:30 p.m. – 3:45 p.m.   VATS – Mediastinal Lymph Node Dissection for NSCLC
Scott J. Swanson, MD
Brigham and Women’s Hospital
3:45 p.m. - 4:00 p.m.   Thoracoscopic Thymectomy
Stephen D. Cassivi, MD
Mayo Clinic
4:00 p.m. - 4:15 p.m.   VATS Segmentectomy
Joshua R. Sonett, MD
Columbia University
4:15 p.m. - 4:30 p.m.   Superior Vena Cava Resection and Reconstruction
Thomas K. Waddell, MD, PhD
University of Toronto
4:30 p.m. - 4:45 p.m.   Video-Assisted Mediastinal Lymphadenectomy (VAMLA)
Todd L. Demmy, MD
Roswell Park Cancer Center
4:45 p.m. - 5:00 p.m.   Chest Wall Resection and Reconstruction
Gaetano Rocco, MD
National Cancer Institute – Italy
5:00 p.m.   ADJOURN TO WELCOME RECEPTION IN EXHIBIT HALL
 
SUNDAY, MAY 8, 2011 | C. WALTON LILLEHEI RESIDENT FORUM SESSION
3:00 p.m. - 5:00 p.m.   14th Annual C. Walton Lillehei Resident Forum
Chairs: J. William Gaynor, MD
Children’s Hospital of Philadelphia

Patrick M. McCarthy, MD
Northwestern University
(7 minutes presentation, 8 minutes discussion)
   
L1   Serum Levels of Neuron-Specific UCH-L1 Can Predict Brain Injury in a Canine Model of Hypothermic Circulatory Arrest
George J. Arnaoutakis1, Timothy J. George1, Kevin K. Wang6, Mary Ann Wilson3,7, Jeremiah G. Allen1, Eric S. Weiss1, Mary E. Blue2,7, C. C. Talbot5, Juan C. Troncoso4, Michael V. Johnston2,7, William A. Baumgartner1

1. Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD, United States. 2. Neurology, The Johns Hopkins Medical Institutions, Baltimore, MD, United States. 3. Neuroscience, The Johns Hopkins Medical Institutions, Baltimore, MD, United States. 4. Neuropathology, The Johns Hopkins Medical Institutions, Baltimore, MD, United States. 5. Institute of Genetic Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, United States. 6. Banyan Biomarkers, Alachua, FL, United States. 7. Hugo W. Moser Research Institute, Kennedy-Krieger, Baltimore, MD, United States.
L2   Pretreatment Strategy with Adenosine A2A Receptor Agonist Attenuates Reperfusion Injury in a Preclinical Porcine Lung Transplantation Model
Damien J. LaPar1, Abbas Emaminia1, Ivan K. Crosby1, Ashish K. Sharma1, Heather M. Sumner2, Christine L. Lau1, Victor E. Laubach1, Irving L. Kron1

1. Surgery, University of Virginia, Charlottesville, VA, United States. 2. Pathology, University of Virginia, Charlottesville, VA, United States.
L3   Selective Left Ventricular Restraint Significantly Decreases Transmural Pressure and Indices of Myocardial Oxygen Consumption
Suyog A. Mokashi, Lawrence S. Lee, Jan D. Schmitto, Rita Laurence, Siobhan McGurk, Lawrence H. Cohn, R. Morton Bolman, III, Frederick Y. Chen

Cardiac Surgery, Brigham and Women’s Hospital, Boston, MA, United States.
L4   Cardioprotection Against Myocardial Infarction by Ischemic Pre- and Post-Conditioning are Both Completely Abrogated by Acute Hyperglycemia
Sara A. Hennessy1, Zequan Yang1, Yuan Liu1, David R. Jones1, Brent A. French2, Irving L. Kron1

1. Department of Surgery, University of Virginia, Charlottesville, VA, United States. 2. Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States.
L5   The Bone Marrow Microenvironment Induces a “Mesenchymal/Stem Cell” Phenotype and Therapeutic Resistance in Non-Small Cell Lung Cancer Cells
Antonio Coppolino1, Ding Cheng Gao1, Raffaella Sordella2, Vivek Mittal1, Nasser K. Altorki1, Brendon M. Stiles1

1. Cardiothoracic Surgery, Weill Cornell Medical College, New York, NY, United States. 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
L6   Hypercholesterolemia and Chronic Ischemia Alter Myocardial Responses to Selective Cyclooxygenase-2 Inhibition
Louis M. Chu1, Michael Robich1,2, Antonio D. Lassaletta1, Shu-hua Xu2, Thomas Burgess1, Yuhong Liu1, Nicholas Sellke1, Frank W. Sellke1

1. Surgery, Alpert Medical School of Brown University, Providence, RI, United States. 2. Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
L7   Lung Cancer Tumor-Initiating Cells Overexpress GADD34 and Are Sensitive to Viral Oncolysis
Joshua Carson1,2, Susanne Carpenter1, Drew Marano1, Valerie W. Rusch1,2, Yuman Fong1

1. Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. 2. Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States.
L8   Statins Attenuate Growth and Malignant Potential of Human Esophageal Adenocarcinoma Cells
Miral R. Sadaria1, Amy E. Reppert1, Jessica A. Yu1, Xianzhong Meng1, David A. Fullerton1, T. Brett Reece1, Michael J. Weyant1

1. Surgery, University of Colorado at Denver and Health Sciences Center, Aurora, CO, United States.
5:00 p.m.   ADJOURN TO WELCOME RECEPTION IN EXHIBIT HALL

 
Policies | Find a Surgeon | About | Contact
We Model Excellence
 Follow AATS on Facebook
Copyright © 2012 American Association for Thoracic Surgery
All rights reserved. IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.